A randomized double-blind controlled trial for specific transcranial magnetic stimulation for different symptoms of Parkinson's disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022875

Enrollment

Unknown

Registered

2019-04-29

Start date

2019-06-03

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

1:specific transcranial magnetic stimulation

2:M1 high frequency rTMS

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Primary Parkinson's disease confirmed according to the diagnostic criteria for the diagnosis of Parkinson's disease in China (there must be one or more of exercise retardation, combined with static tremor, rigidity, and postural instability, no Other issues that are clear or suspected to cause Parkinson's syndrome), 1 <= Hoehn-Yahr classification <= 4; 2. voluntary participation, the patient understands and signs or the informed consent of his immediate family; 3. long-term regular acceptance of Parkinson's disease medical treatement.

Exclusion criteria

Exclusion criteria: Those who have history of epilepsy or family history of epilepsy, metal pacemakers in the body, metal implants in the brain, cochlear implants, etc. are not suitable for transcranial magnetic stimulation.

Design outcomes

Primary

Measure	Time frame
UPDRS;	—

Secondary

Measure	Time frame
Resting state fMRI;PAS;	—

Countries

China

Contacts

Public ContactYuhui Chen

Shanghai Tongji Hospital

chenyuhui2005@126.com+86 13341688656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026